vail symposium 2015 dr. karli stem cell panel

41
David C. Karli, MD, MBA Steadman Clinic Vail, CO 2015

Upload: vail-symposium

Post on 07-Apr-2016

217 views

Category:

Documents


0 download

DESCRIPTION

Dr. Karli's powerpoint presentation from the Vail Symposium's 2015 Stem cell panel.

TRANSCRIPT

Page 1: Vail symposium 2015 Dr. Karli Stem Cell panel

David C. Karli, MD, MBA Steadman Clinic Vail, CO 2015

Page 2: Vail symposium 2015 Dr. Karli Stem Cell panel

Medical School: University of Maryland

Residency: Harvard Medical School Board Certified Physical Medicine & Rehabilitation

Practice: Harvard Medical School Faculty

Steadman Clinic (Since 2002)

MBA: University of Denver Daniels School of Business

Page 3: Vail symposium 2015 Dr. Karli Stem Cell panel

Work with Regenerative Medical Therapies since 2004

Directly involved in treatment of over 8000 patients Via Injection

Surgical Implantation

Biotech Industry Consultant

Founder – Greyledge Technologies, LLC

Primary clinical/research focus to date: Platelet Rich Plasma

Bone Marrow Blood Concentrate

Page 4: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 5: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 6: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 7: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 8: Vail symposium 2015 Dr. Karli Stem Cell panel

: is a branch of translational research in tissue engineering and molecular biology which deals with the “process of replacing, engineering or reengineering human cells, tissues or organs to restore or establish normal function.”

Page 9: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 10: Vail symposium 2015 Dr. Karli Stem Cell panel

Taking nonfunctional tissue and making it functional again using biology Systemic

Nutrition, Sleep, Exercise, Supplementation, Hormone and Metabolic Optimization, Psychological Health

Tissue Specific

Cellular Therapy Therapy in which cellular material is injected

into a patient; this generally means intact, living cells; to achieve a therapeutic effect

Page 11: Vail symposium 2015 Dr. Karli Stem Cell panel

Platelet White Blood Cell

Page 12: Vail symposium 2015 Dr. Karli Stem Cell panel

Autologous (for this talk)

Tissue obtained from the same individual

Allogeneic

Tissue obtained from another individual

Page 13: Vail symposium 2015 Dr. Karli Stem Cell panel

Stem Cell Cell that is capable of

giving rise to indefinitely more cells of the same type, and other kinds of cells Adult (Bone Marrow,

Muscle, Fat)

Embryonic

Placental Derived

Page 14: Vail symposium 2015 Dr. Karli Stem Cell panel

Constant: The body will attempt to fix itself Will not always succeed…

Some tissues more “efficient” than others In part – secondary

to blood supply:

Skin, muscle – great efficiency

Tendon, ligament – moderate efficiency

Disc, joint cartilage, meniscus – poor efficiency

Page 15: Vail symposium 2015 Dr. Karli Stem Cell panel

Basic conditions for healing:

Energy source Glucose (+/- oxygen)

Building blocks for repair

Amino acids Proteins

Replacement cells

Growth Factors

Light switch

Optimal local environment to facilitate repair

All typically carried/modulated by blood

Page 16: Vail symposium 2015 Dr. Karli Stem Cell panel

Manipulation of blood tissue into an implantable product which would augment and amplify the body’s capacity to heal itself

Page 17: Vail symposium 2015 Dr. Karli Stem Cell panel

More than clotting agents: Anatomy:

Contractible cytoskeleton Granules : contain GFs,

clotting factors, and numerous proteins

When Activated:

Coordinate healing

Proteins released from injured tissue = trigger for activation

Page 18: Vail symposium 2015 Dr. Karli Stem Cell panel

Autologous Biotherapies - Phase I:

Biotherapeutic created by whole blood component separation and concentration of platelets and/or White Blood Cells

Implanted to augment tissue healing

Page 19: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 20: Vail symposium 2015 Dr. Karli Stem Cell panel

Bio therapeutic created by marrow blood component separation and concentration of platelets and/or White Blood Cell Populations

Page 21: Vail symposium 2015 Dr. Karli Stem Cell panel

Delivers complex

collection of cells and bioactive proteins that control maintenance of our body to area of injury or disease to stimulate repair Pluripotent cells “Stem-like” cells Stem cells Platelets

Page 22: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 23: Vail symposium 2015 Dr. Karli Stem Cell panel

Theories/evidence for therapeutic effect: 1. Cells integrate into native tissue and become new

tissue

2. Cells stimulate native cells to proliferate and become new tissue

3. Cells release proteins to induce healing response

4. Cells regulate the local environment to become less toxic (block inflammation)

5. A combination of the above…

Page 24: Vail symposium 2015 Dr. Karli Stem Cell panel

Potential/Demand have driven access to biologic therapies (including “stem cells”) - naturally outpacing scientific validation through research

Access to emerging therapies in fee for service model: Low Barrier to entry

Patient Controlled Care… Patient responsible for researching options for care =

Patient Consumer

Page 25: Vail symposium 2015 Dr. Karli Stem Cell panel

Should You Investigate Regenerative Medicine?

What Can You Expect?

Page 26: Vail symposium 2015 Dr. Karli Stem Cell panel

Tendonitis/tendonopathy/partial thickness tear Shoulder, Elbow, Hip, Knee, Foot/Ankle

Ligamentous injury/tears (MCL/ACL, Ankle, Elbow) Muscle injury (sprains/strains)/tears Bursitis/ITB Osteoarthritis

Knee, Shoulder, Hip, Ankle, Small Joint Knee Meniscal Tears Hip/Shoulder Labral Tears

Plantar fasciitis Spine?

Page 27: Vail symposium 2015 Dr. Karli Stem Cell panel

Disc Regeneration?

Page 28: Vail symposium 2015 Dr. Karli Stem Cell panel

Arthroscopy

Knee Hip

Page 29: Vail symposium 2015 Dr. Karli Stem Cell panel

Is your problem appropriate for treatment? History and Physical Exam

Here is what we know from: Research Anecdotal Application

Safety and Risk Discussion

Your money is applied to buy an outcome: What is the likelihood of success?

8 out of 10 rule

The treatment may not work!

What will the experience be like?

Page 30: Vail symposium 2015 Dr. Karli Stem Cell panel

Cellular Harvest is a technical procedure and not without risk Not routinely taught in standard medical training

programs!

How many has your practitioner performed?

Can they do so comfortably?

Page 31: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 32: Vail symposium 2015 Dr. Karli Stem Cell panel

Cellular implants are likely to do nothing if not implanted accurately and safely.

Easy to perform injections poorly

Technical procedures – not without risk!

Guided injections require extensive and nonstandard training.

Is your practitioner going to guide the implantation?

How many has he/she done?

Page 33: Vail symposium 2015 Dr. Karli Stem Cell panel

Are All Created Equal?

Page 34: Vail symposium 2015 Dr. Karli Stem Cell panel

Does your practitioner know exactly what is being implanted?

A majority of PRP and BMC has been implanted without quantitative control!

Page 35: Vail symposium 2015 Dr. Karli Stem Cell panel

!PRP#/#BMCC#AUTOLOGOUS#BLOOD#PRODUCT#RECORD#

!

FORM&10036.00!MARCH!2013!!!!!!!!!!!!!©!Greyledge!Technologies,!LLC!2010!!

#

!BMCC#/#PRP#ANALYSIS#!

!Platelet!Concentration!!

!_________________________!!Platelets/µL!

!WBC!Concentration!!

!_________________________!!WBC/µL!

!Neutrophils!!

!_________________________NEU/µL!/_________________%!

!

Lymphocytes!!

!

_________________________LYM//µL!/_________________%!

!

Monocytes!!

!

_________________________MONO/µL!/_______________%!

!

Eosinophils!!

!

_________________________EOS/µL!/_________________%!

!Basophils!

!

!_________________________BASO/µL!/_______________%!

!RBC!Concentration!

!

!_________________________!!RBC/µL!

!BMCC!/!PRP!Volume!

!

!_________________________!!cc!

!BMCC!/!PRP!Concentration!!

!__________________________!!!x!Whole!Blood!

!!!

Place!Patient!Label!Here!!!!

!

DATE:!!

!

!PRP#/#BMCC#AUTOLOGOUS#BLOOD#PRODUCT#RECORD#

!

FORM&10036.00!MARCH!2013!!!!!!!!!!!!!©!Greyledge!Technologies,!LLC!2010!!

!

APPROVAL!SIGNATURES:!

______________________________________________! ________________________!

Technician,!Greyledge!Technologies! ! ! ! DATE!

______________________________________________! _______________________!

VVSC!Designated!OR!Staff!Member! ! ! ! DATE!

By#signing#this#checklist#I#(we)#verify#that#all#information#above#has#been#completed#and#that#the#sample#

Identifiers#match#the#patient#medical#record.#!

!BMCC#/#PRP#WHOLE#BLOOD#ANALYSIS#!

!

Platelet!Concentration!!

!

_________________________!!Platelets/µL!

!

WBC!Concentration!!

!

_________________________!!WBC/µL!

!

Neutrophils!!

!

_________________________NEU/µL!/_________________%!

!Lymphocytes!

!

!_________________________LYM/µL!/_________________%!

!Monocytes!

!

!_________________________MONO/µL!/_______________%!

!Eosinophils!

!

!_________________________EOS/µL!/_________________%!

!Basophils!

!

!_________________________BASO/µL!/________________%!

!RBC!Concentration!!

!_________________________!!RBC/µL!

!Whole!Blood!Volume!!

!_________________________!!cc!

35

Page 36: Vail symposium 2015 Dr. Karli Stem Cell panel

Education:

What to expect Pain Control

Time to improvement

What to watch out for Emergency Contact

Activity Modification

Therapy/Exercise

Follow Up

Page 37: Vail symposium 2015 Dr. Karli Stem Cell panel

Autologous, Point of Care Biologics in my opinion are reasonable and work often for appropriate Indications PRP – soft tissue indications

BMC – OA/cartilage/bony indications

PRP and BMC if performed properly are safe procedures

Accurate standardization/quantification of every product should be a necessity Higher quality research, scientific validation and safety

37

Page 38: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 39: Vail symposium 2015 Dr. Karli Stem Cell panel
Page 40: Vail symposium 2015 Dr. Karli Stem Cell panel

firmly believed in: bloodletting: bleeding patients, as well as purges using calomel and

other toxic substances

Some even blamed Rush's bleeding for hastening the death of: Benjamin Franklin, as well as George Washington, and

Rush insisted upon being bled himself shortly before his death

Trivia: Why did some patients survive/recover?

Page 41: Vail symposium 2015 Dr. Karli Stem Cell panel

Web Search PRP, BMC and location

Educational Symposium (TOBI)

“stem cell clinical trials for …”

Clinical Trials: Clinicaltrials.gov

Eurostemcell.org

Webmd.com

Nationalstemcellfoundation.org

Blogosphere LinkedIn (BOS)